RUFQA CARE WELLNESS CHEWABLE TABLET (PINK GUAVA FLAVOUR)
RUFQA CARE WELLNESS CHEWABLE TABLET (PINK GUAVA FLAVOUR) : Product registered in Malaysia. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.
NPRA, Malaysian pharmaceutical products register, retrieved 27 October 2026.
Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0
The foreign register category does not determine the regulatory category of the product in France.
French and European references for recognised ingredients
- Conditions légales
Camellia sinensis (L.) Kuntze: Seules sont admises la poudre issue du broyage des feuilles et les préparations obtenues à partir des solvants suivants : l'eau, l'alcool à 25 % (v/v), ainsi que les solvants autorisés pour la décaféination ou la suppression des matières irritantes et amères. Les recommandations d'emploi ne doivent pas conduire à une ingestion quotidienne d'EGCG supérieure à 300 mg. L'étiquetage doit comporter des avertissements déconseillant leur prise en dehors des repas, ainsi que leur consommation par les enfants, les adolescents, les femmes enceintes ou allaitantes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Contains tea (Camellia sinensis). Green tea extracts must provide less than 800 mg of epigallocatechin-3-gallate per daily portion, with mandatory warnings.
annexe III, partie B (règlement (UE) 2022/2340). Regulation (EC) No 1925/2006, latest consolidated version, retrieved 21 October 2026, source updated 26 November 2025.
Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.
Published composition
| Published ingredient | Published text and quantity | Identified nutrient or substance |
|---|---|---|
| Plantago ovata | Plantago ovata[16 mg,800 mg] | Not identified |
| Camellia sinensis | Camellia sinensis[8 mg,800 mg] | Not identified |
| Garcinia cambogia | Garcinia cambogia[48 mg] | Not identified |
| Musa sapientum | Musa sapientum[48 mg,800 mg] | Not identified |
| Irvingia gabonensis | Irvingia gabonensis[40 mg,800 mg] | Not identified |
| Malus domestica | Malus domestica[40 mg] | Not identified |
The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.
Product record
- Registration number
- MAL26076063TC
- Type
- Natural product
- Published status
- PRODUCT APPROVED
- Licence holder
- RUFQA CARE GLOBAL
- Manufacturer
- DS Pharma Herbs Sdn. Bhd.
- Registration period starting
- 2026-07-07
- Published validity end
- 2031-07-07
Original register data
View published fields and their variants
- Active ingredients
- Plantago ovata[16 mg,800 mg],Camellia sinensis[8 mg,800 mg],Garcinia cambogia[48 mg],Musa sapientum[48 mg,800 mg],Irvingia gabonensis[40 mg,800 mg],Malus domestica[40 mg]
- Valid until
- 2031-07-07
- Registration date
- 2026-07-07
- Published description
- NATURAL PRODUCT
- Licence holder
- RUFQA CARE GLOBAL
- Producer
- DS Pharma Herbs Sdn. Bhd.
- Published name
- RUFQA CARE WELLNESS CHEWABLE TABLET (PINK GUAVA FLAVOUR)
- Published reference
- 2026021221389T
- Registration number
- MAL26076063TC
- Published status
- PRODUCT APPROVED
Official source
View the official register, number MAL26076063TC
Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Irvingia gabonensis
Read the warning, when it applies and the studies cited
AFRICAN WILD MANGO - IRVINGIA GABONENSIS
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes (Ross 2011; Ngondi et al. 2009; Adamson et al. 1986).
Sources cited by Health Canada (3)
- Adamson I, Okafor C, Abu-Bakare A. Erythrocyte membrane ATPases in diabetes: effect of dikanut (Irvingia gabonensis). Enzyme 1986; 36(3): 212-215. PubMed
- Ngondi JL, Etoundi BC, Nyangono CB, Mbofung CM, Oben JE. IGOB131, a novel seed extract of the West African plant Irvingia gabonensis, significantly reduces body weight and improves metabolic parameters in overweight humans in a randomized double-blind placebo controlled investigation. Lipids in Health and Disease 2009; 8:7. PubMed Randomised trial
- Ross MS. A proprietary seed extract of Irvingia gabonensis is found to be effective in reducing body weight and improving metabolic parameters in overweight humans. Holistic Nursery Practice 2011; 235(4): 215-217.
Condition of application: Antioxidant, cholesterol, glucose.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant.
Contraindications
Condition of application: Weight management.
Do not use if you are pregnant.
Known adverse reactions
Stop use if you experience symptoms of hypoglycaemia including feelings of anxiety, dizziness, tremor, sweating, nausea or headache (Adamson et al. 1986; Ngondi et al. 2009; Oben et al. 2008a,b).
Sources cited by Health Canada (3)
- Adamson I, Okafor C, Abu-Bakare A. Erythrocyte membrane ATPases in diabetes: effect of dikanut (Irvingia gabonensis). Enzyme 1986; 36(3): 212-215. PubMed
- Ngondi JL, Etoundi BC, Nyangono CB, Mbofung CM, Oben JE. IGOB131, a novel seed extract of the West African plant Irvingia gabonensis, significantly reduces body weight and improves metabolic parameters in overweight humans in a randomized double-blind placebo controlled investigation. Lipids in Health and Disease 2009; 8:7. PubMed Randomised trial
- Oben JE, Ngondi JL, Blum K. Inhibition of Irvingina gabonensis seed extract (OB131) on adipogenesis as mediated via down regulation of the PPARgamma and leptin genes and up- regulation of the adiponectin gene. Lipids in Health and Disease 2008a; 7:44. PubMed
They concern the ingredient, not this product or its dose. They do not replace medical advice.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “RUFQA CARE WELLNESS CHEWABLE TABLET (PINK GUAVA FLAVOUR)”, https://compoatlas.com/en/supplements/malaysia/MAL26076063TC-rufqa-care-wellness-chewable-tablet-pink-guava-flavour, updated 27 October 2026.